Nextferm Technologies Ltd. · TASE:NXFR.M
Nextferm Technologies — Investor Presentation (April 2024)
22 slides from Nextferm Technologies's investor presentation, April 2024
Slide 1: NextFerm Technologies: Leading The Alternative Protein Revolution
NEXTFERM TECHNOLOGIES Leading The Alternative Protein Revolution April-2024
Slide 2: Disclaimer
This presentation is intended for the provision of non-comprehensive information for the sake of convenience solely. You are hereby referred to the full prospectus and immediate and periodic reports filed by the company with the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd. for DI
Slide 3: About NextFerm
ABOUT NEXTFERM LEADING THE ALTERNATIVE PROTEIN REVOLUTION Experienced team in the world of Nutrition and food-tech ProteVin™ - The only vegan protein with animal like nutritional value and neutral taste Innovative technology based Demands for ProteVin™ from the growing alternative protein market Pro
Slide 4: The team
NEXTFERM The team Experienced Team in the Food and Food-tech Industries Company management is comprised of former Senior Management of Enzymotec, which developed innovative ingredients within the world of nutrition. Enzymotec reached revenues of over $80M and went public (NASDAQ) during 2013, with a
Slide 5: ProteVin tested and approved for wide variety of food and supplement products
ProteVin was tested and approved as appropriate for wide variety of food and dietary supplement products 5
Slide 6: Alternative protein market expected to reach at least $290B by 2035
“Every Tenth Portion of Meat, Eggs, Dairy, and Seafood Eaten Around the Globe Will Be Made from Alternative Proteins by 2035, ” BY 2035, THE ALTERNATIVE PROTEIN MARKET (B2C) IS EXPECTED TO REACH AT LEAST $290B (*) (*) https://www.bcg.com/press/23march2021-alternative-protein-market-reach-290-billion
Slide 7: Over $300M yearly growth in demand for vegan protein powder
OVER $300M (*) YEARLY GROWTH IN DEMAND FOR VEGAN PROTEIN POWDER (*) https://www.gminsights.com/industry-analysis/vegan-protein-powder-market Growth for 2022 and forecast for 2032 7
Slide 8: Commercial Status
- COMMERCIAL STATUS Above 100 food and • 5 launches Above $3M dietary supplement • Many Customers in PO’s & Supply companies are evaluating are waiting for ProteVIn™. Agreement ProteVin™ 8
Slide 9: Launches
5 LAUNCHES Sawy /eggie Powder Protein % VEGETARIAN " PROTEIN 4 @ nextferm
Slide 10: ‘¢ Spacemi
209. ‘¢ Spacemi Ik EDISON AWARDS & BLACK &VEATCH ) EDISON AW/ ban 4 ec . 7 To EpISn™ ‘ ol ae Nate EDISON AWARDS UNDATION © EDISON AWARDS — 15 @rnextferm 0 Ef
Slide 11: ProteVin among the most effective solutions in the market
PROTEVIN AMONG THE MOST EFFECTIVE SOLUTIONS IN THE MARKET Currently In the market Innovative Proteins NextFerm innovation Plant based protein sources: Precise fermentation Protevin™ - Poor nutrition value & cell-culture: Superior Nutrition - Distinguished Taste - Far from mature Neutral taste - Supe
Slide 12: Breakthrough Technology
BREAKTHROUGH TECHNOLOGY FOR PRODUCING YEAST-DERIVED, INNOVATIVE, FUNCTIONAL VEGAN FOOD INGREDIENTS Yeast Improvement Fermentation Separation & Scale-up (Patented, Non-GMO) (Cost-effective) Purification (from Lab to Industry) Improvement of yeast Process optimization for Development of efficient Impl
Slide 13: Vegan Proteins Options in the Market
VEGAN PROTEINS OPTIONS IN THE MARKET Other Yeast Protein Source ProteVin™ Soy Pea & Rice Proteins (*) Vegan Source + + + + No Allergens/impurities + + - - Sustainability ++ ++ + + Taste & Flavor ++ - + - Applicability ++ - + - Amino Acid Composition (AA) ++ ++ - - Digestibility ++ ++ + + 13 (*) Prod
Slide 14: Zero Waste Profitable Process
ZERO WASTE PROFITABLE PROCESS 1Kg of: ProteVin™ Multi billions $ market 1Kg of Yeast Yeast Extract ~$2B market (*) Cell Wall (*) https://www.fortunebusinessinsights.com/yeast-extract-market-106656 14
Slide 15: Production – Kothari India Strong Strategic Partnership
PRODUCTION – KOTHARI INDIA STRONG STRATEGIC PARTNERSHIP 15
Slide 16: Our Mission - Big Scale Execution of Proven Case Study
OUR MISSION - BIG SCALE EXECUTION OF PROVEN CASE STUDY Profitable Production Existing Demands 16 16
Slide 17: ProteVin – Operational Plan
PROTEVIN – OPERATIONAL PLAN March Q2- Year 2024 2024 2025 First Line Installment & Capacity growth Further Capacity commissioning growth The first line was installed and By the end of Q2, the company will During 2025 additional stage of operated, and the commissioning increase capacity to enable exp
Slide 18: Key Goals for 2024
KEY GOALS FOR 2024 Expansion of the production line for ProteVin™ in India, which will enable annual revenues of approximately $4 million; expected to be completed during the second quarter of 2024 Keep growing market demands and receipt of additional purchase orders for ProteVin™ from the US, Europ
Slide 19: Achievements 2022, 2023 and Strategic Market Expansion Plan
Achievements 2022 Achievements 2023 Strategic market expansion plan Commissioning GFR Production agreement Dairy alternative Well-being Senior Nutrition Commercial Launch Increase demands products Strain commercial scale-up Creating demands - Growth Project 1 Sports Food alternative Infant Nutrition
Slide 20: Financial Information
FINANCIAL INFORMATION Cash & cash equivalent as of December 31st, 2023 : ~$3.3M The cash will be use for ongoing activity and for establishing Market production in India B2C 2021 $36M were raised (2014-2023) Public Offering in the TASE (March 2023): Raised $5M Private Placement (December 2021): Rais
Slide 21: Financial Information
FINANCIAL INFORMATION USD in thousands 2023 2022 2021 STATEMENT OF OPERATION Net Revenues 283 262 242 Gross (Loss) Profit (**) (696) (1,122) 23 Market Operating Loss (4,360) (8,100) (4,467) B2C Adjusted 2021 EBITDA (*) (3,670) (7,275) (4,113) BALANCE SHEET Cash, cash equivalents and Short term depos
Slide 22: Thank You!
THANK YOU!
NextFerm Technologies — Investor Presentation (April 2024) on 6ix